ReviewCurrent hematologic malignancy reports2017

Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.

Ravi Kishore Narra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.